Sign In
Buy BVNKF
$27.69
+0 (+0%)
At Close: Jul 31, 2026
Bavarian Nordic (BVNRY) Stock Gets a Boost From New Canadian Contract
10:03am, Tuesday, 07'th Jun 2022
Bavarian Nordic (BVNRY) stock is rising higher on Tuesday after announcing a new deal with Canada to purchase one of its vaccines. The post Bavarian Nordic (BVNRY) Stock Gets a Boost From New Canadian
Bavarian Nordic Conference Call: General Monkeypox Update
11:30am, Friday, 03'rd Jun 2022
COPENHAGEN, Denmark – June 3, 2022 - Bavarian Nordic A/S (OMX: BAVA) will host an investor and analyst conference call on Tuesday, June 7, 2022, at 3:00 pm CEST (9:00 am EDT) to provide a general up
Bavarian Nordic raises sales guidance after monkeypox vaccine order
06:19am, Wednesday, 25'th May 2022
Danish biotechnology company Bavarian Nordic on Wednesday lifted its sales outlook and now expects a smaller operating loss this year after signing a contract with an undisclosed country for the suppl
Vaccine-maker shares soar on monkeypox outbreak
10:57am, Tuesday, 24'th May 2022
CNBC's Meg Tirrell joins 'Squawk Box' to break down the companies with vaccines against monkeypox as multiple countries respond to a growing number of cases.
Bavarian Nordic A/S (BVNKF) CEO Paul Chaplin on Q1 2022 Results - Earnings Call Transcript
01:37pm, Monday, 09'th May 2022
Bavarian Nordic A/S (OTCPK:BVNKF) Q1 2022 Earnings Conference Call May 9, 2022 8:00 AM ET Company Participants Rolf Sass - Investor Relations Paul Chaplin - President & Chief Executive Officer Henrik
Bavarian Nordic to Host Full Year 2021 Results Conference Call
02:00pm, Monday, 28'th Feb 2022
COPENHAGEN, Denmark – February 28, 2022 - Bavarian Nordic A/S (OMX: BAVA) will announce its 2021 annual report on Friday, March 4, 2022.
Bavarian Nordic's (BVNKF) CEO Paul Chaplin on Q3 2021 Results - Earnings Call Transcript
01:55pm, Friday, 12'th Nov 2021
Bavarian Nordic's (BVNKF) CEO Paul Chaplin on Q3 2021 Results - Earnings Call Transcript
Bavarian Nordic's COVID-19 Funding Agreement with the Danish Ministry of Health Receives Final Approval from Parliament
04:40am, Friday, 24'th Sep 2021
COPENHAGEN, Denmark, September 24, 2021 – Bavarian Nordic A/S (OMX: BAVA) announced today that the funding agreement recently entered with the Danish Ministry of Health to further advance the develo
Bavarian Nordic A/S (BVNKF) CEO Paul Chaplin on Q2 2021 Results - Earnings Call Transcript
02:58pm, Wednesday, 25'th Aug 2021
Bavarian Nordic A/S (BVNKF) CEO Paul Chaplin on Q2 2021 Results - Earnings Call Transcript
Bavarian Nordic Receives Funding from the Danish Ministry of Health to Advance the Development of COVID-19 Booster Vaccine
07:45am, Monday, 23'rd Aug 2021
COPENHAGEN, Denmark, August 23, 2021 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company has entered a funding agreement with the Danish Ministry of Health to further advance the deve
Bavarian Nordic A/S - Articles of Association
06:32am, Thursday, 10'th Jun 2021
Updated Articles of Association for Bavarian Nordic A/S.
COPENHAGEN, Denmark, June 10, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today received information about the following transactions of the company's shares/related securities by persons
Bavarian Nordic's (BVNKF) CEO Paul Chaplin on Q1 2021 Results - Earnings Call Transcript
12:52am, Friday, 28'th May 2021
Bavarian Nordic's (BVNKF) CEO Paul Chaplin on Q1 2021 Results - Earnings Call Transcript
Dynavax, Bavarian Nordic Ink Distribution Pact For Hepatitis B Vaccine In Germany
08:47am, Thursday, 27'th May 2021
Dynavax Technologies Corporation (NASDAQ: DVAX) has entered into a commercialization agreement with Bavarian Nordic for the marketing and distribution of HEPLISAV B, the Hepatitis B vaccine in Germ
Bavarian Nordic A/S - Articles of Association
04:48am, Monday, 03'rd May 2021
Updated Articles of Association for Bavarian Nordic A/S.
